Follow the Money Trail

To make sense of something that seems bureaucratic and nonsensical, follow the money.

The money says this: when a person is diagnosed as having cancer, as many as seven people are directly employed in their treatment.

With hundreds of thousands of people being diagnosed with cancer each year, this ensures that seven times as many jobs are secured.

Billions of dollars are poured into the fundraising process for cancer research, which is itself a huge industry employing thousands.

A small percentage of those funds not used up in the fundraising process filter through to a self-perpetuating research process. How is it possible, under these circumstances, to remove a vested interest in not finding a cure from this huge, convoluted bureaucratic process?

Add to this that the drug companies have stockpiles of current treatments that are very toxic, are limited in their results and are fetching very good prices.

This means that it would not be sensible to declare an easy, cheap, non-toxic and readily available solution, which requires little or no specialist training in its administration, as obtainable on the market any time soon. It could be seen as being contrary to certain vested interests or justified as “not good for the stockholders”.

This untenable situation could be defended on the grounds of economic rationalism, i.e., “Let a few of them die for the greater good”. Yet the reality is that one part of society is surviving on the suffering and death of the other.

Many people might believe that a serious, fraudulent, mass-life-threatening situation could never happen in modern times, yet I was an eyewitness to open statements that such shocking economic rationalism is a driving force behind the cancer industry.

Website Publisher’s Comment

The article, Laetrile vs Cancer: An Australian Story that was originally published in Nexus Magazine and is published on this website has been done so with the permission of the author, Rev. Dr Shè D’Montford and with the permission of Nexus Magazine. There has been slight adjustment to the formatting to allow for easier reading on the web pages. Do note that the article is copyrighted and may not be reprinted without permission. If you publish it on your website, "Fair Use" applies, only publish a small portion or quote and include a link to this site.